Anatomical MRI study of basal ganglia in major depressive disorder
Introduction
Major depressive disorder (MDD), the most common psychiatric disorder (Kessler et al., 1994), is foreseen to be the second most frequent cause of disability by the year 2020 (Murray and Lopez, 1996). Although MDD has no established etiology or pathophysiology, the study of its biological aspects has acquired a prominent role, especially in the last three decades.
Fronto-subcortical circuits have been described as important networks of the brain, participating directly in brain–behavior interactions. They are named accordingly with their function or the region they are efferent from. Although each of them constitutes a closed loop where dedicated neurons remain segregated from the parallel networks, they have ‘open’ afferent and efferent components that establish connections with ‘open components’ from other circuits, sharing specific functions with them (Mega and Cummings, 1994). At least two interconnected frontal-subcortical circuits, the limbic-striatal-pallidal-thalamic and the limbic-thalamo-cortical, appear to play an important role in MDD pathophysiology (Drevets et al., 1992). Other studies suggest that circuits involving prefrontal cortex, amygdala, basal ganglia, and thalamus are probably disturbed in MDD. Increasing evidence suggests dysfunction in various elements of these circuits, even though the precise mechanisms involved have not been elucidated (Drevets et al., 1992, Cummings, 1993, Guze and Gitlin, 1994, Mayberg, 1997, Soares and Mann, 1997a, Soares and Mann, 1997b).
Although it is very difficult to assess systematically complex brain–behavior interaction as observed in MDD, studies addressing neurological disorders that present a high prevalence of depression during their course have provided some important insights. In this sense, mood disturbances can be observed in animals with limbic lesions; motivation and pleasurable sensation appear to be related to hypothalamus and upper brain stem stimulation; feelings of helplessness and worthlessness frequently observed in depressed patients may derive from frontal lobe dysfunction; and motor manifestations such as alteration in gait and posture observed in depressive states may derive from basal ganglia dysfunction (Cummings, 1993).
New strategies for testing pathophysiological theories in mental disorders have arisen with the development of neuroimaging techniques, which permit in vivo visualization and quantification of the gross anatomy, physiology and neurochemistry of the brain. In fact, they represent an invaluable advance when compared to postmortem anatomical studies, since the latter suffer interference from many factors related to the death process rather than the psychiatric illness per se. In vivo neuroimaging techniques can be classified into two major groups: functional (PET, SPECT, fMRI and MRS) and structural (CT and MRI). Despite the belief that ‘episodic illnesses’ would involve only biochemical rather than histopathological abnormalities, MDD, like epilepsy, has been shown to involve both anatomical and functional abnormalities (Guze and Gitlin, 1994, Soares and Mann, 1997a, Soares and Mann, 1997b).
Decreased metabolic activity in dorsolateral and medial prefrontal cortex areas has been reported by most but not all PET (positron emission tomography) studies involving depressed patients (Baxter et al., 1989, Bench et al., 1992, Biver et al., 1994, Mayberg, 1997). Other PET and SPECT (single photon emission computed tomography) studies have found reduced metabolism/blood flow in the basal ganglia of depressed patients compared to healthy controls (Austin et al., 1992, Baxter et al., 1985, Buchsbaum et al., 1986, Mayberg et al., 1994). Additionally, some investigators have reported a significant increase in blood flow or glucose metabolism of the basal ganglia associated with recovery in MDD (Scott et al., 1994, Henry et al., 2001).
Magnetic resonance imaging (MRI) is virtually the only structural neuroimaging technique available to investigate basal ganglia abnormalities, since computed tomographic (CT) brain scans do not provide reliable distinction between gray and white matter, and neuropathologic studies have generally utilized small and heterogeneous samples (Baumann et al., 1999, Baumann and Bogerts, 1999). Some but not all structural neuroimaging studies have also found differences between unipolar depressive patients and healthy controls, with patients showing reduced volumes of the caudate and putamen nuclei (Husain et al., 1991, Krishnan et al., 1992, Krishnan, 1993, Dupont et al., 1995, Parashos et al., 1998).
Data from several studies that involved patients suffering from basal ganglia illnesses have also suggested an important role for these structures in MDD pathophysiology. Krishnan (1993) reported a significant correlation between the degree of atrophy in the neostriatum and the presence of depression in Huntington's disease; Murphy et al. (1992) reported basal ganglia lesions in up to 50% of late-onset depressed patients; and other studies have demonstrated an elevated prevalence of depression prior to the onset of motor symptoms in Huntington's disease, a known basal ganglia degenerative illness (Krishnan et al., 1992, Krishnan, 1993).
The main objective of the present MRI study was to investigate possible abnormalities in basal ganglia volumes of MDD patients. In addition, we investigated a possible effect of age and clinical variables on these volumes. We hypothesized that depressed patients would have smaller basal ganglia volumes compared to healthy controls and that the volumes of these structures would inversely correlate with the length of illness, severity of the current episode and the number of previous episodes.
Section snippets
Subjects
Twenty-five patients meeting criteria for MDD, as determined by the Structured Clinical Interview for DSM-IV (Spitzer et al., 1994), were examined. They were all outpatients and were drug-free for at least 2 weeks before the scan. The Hamilton Depression Rating Scale (HDRS) (Hamilton, 1960) was used to assess the severity of depressive symptoms. At the time of the examination, 10 patients were euthymic (did not meet DSM-IV criteria for current depressive episode) and 15 were acutely depressed
Clinical variables
Demographic and clinical characteristics of the sample are summarized in Table 1. Three patients had used antipsychotic medications in the past. Compared with controls, patients were significantly older (41.20±11.04 and 35.06±10.03 years, respectively; t test, t=2.39, d.f.=71; P=0.019), were primarily females (21 F/4 M and 19 F/29 M, respectively; χ2=13.09, d.f.=1, P<0.001), and presented a trend for a lower level of education (χ2=12.446; d.f.=6; P=0.053). Length of illness
Discussion
This study found no significant differences in the volumes of caudate, putamen and globus pallidus in MDD patients compared to healthy controls. These findings persisted even when we excluded male subjects from the analysis, in order to provide a better match for gender in our sample. However, there was a significant interaction between diagnosis and cerebral hemisphere, with MDD patients showing a decreased asymmetry in globus pallidus volumes in comparison with controls.
Our results are in
Acknowledgements
This study was supported by grants MH 01736 and MH 30915 from the National Institute of Mental Health, NARSAD, American Foundation for Suicide Prevention and CAPES Foundation (Brazil). Dr Soares was the 1999–2001 Selo NARSAD Investigator. Dr Lacerda was funded by the Conselho Nacional de Desenvolvimento Cientı́fico e Tecnológico (CNPq)–Brazil.
References (59)
- et al.
An MRI study of temporal lobe structures in men with bipolar disorder or schizophrenia
Biological Psychiatry
(2000) - et al.
Single photon emission tomography with 99mTc-exametazime in major depression and the pattern of brain activity underlying the psychotic/neurotic continuum
Journal of Affective Disorders
(1992) - et al.
The pathomorphology of schizophrenia and mood disorders: similarities and differences
Schizophrenia Research
(1999) - et al.
Frontal and parietal metabolic disturbances in unipolar depression
Biological Psychiatry
(1994) - et al.
Anatomical MRI study of basal ganglia in bipolar disorder patients
Psychiatry Research: Neuroimaging
(2001) - et al.
Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness
Journal of Affective Disorders
(1986) - et al.
Striatal enlargement in rats chronically treated with neuroleptic
Biological Psychiatry
(1998) - et al.
The role of dopamine in mood disorders
Comprehensive Psychiatry
(1992) - et al.
A magnetic resonance imaging study of putamen nuclei in major depression
Psychiatry Research: Neuroimaging
(1991) - et al.
A comparison of stereology and segmentation techniques for volumetric measurements of lateral ventricles in magnetic resonance imaging
Psychiatry Research: Neuroimaging
(1995)
Lithium-induced increase in human brain grey matter
Lancet
Magnetic-resonance morphometry in patients with major depression
Psychiatry Research: Neuroimaging
A quantitative magnetic resonance imaging study of caudate and lenticular nucleus gray matter volume in primary unipolar major depression: relationship to treatment response and clinical severity
Psychiatry Research: Neuroimaging
Basal ganglia choline levels in depression and response to fluoxetine treatment: an in vivo proton magnetic resonance spectroscopy study
Biological Psychiatry
Role of norepinephrine in the pathophysiology and treatment of mood disorders
Biological Psychiatry
The effect of clozapine on caudate nucleus volume in schizophrenic patients previously treated with typical antipsychotics
Neuropsychopharmacology
Short-term effects of electroconvulsive treatment on the uptake of 99mTc-exametazime into brain in major depression shown with single photon emission tomography
Journal of Affective Disorders
The anatomy of mood disorders—review of structural neuroimaging studies
Biological Psychiatry
The functional neuroanatomy of mood disorders
Journal of Psychiatric Research
Reduced volume of limbic system-affiliated basal ganglia in mood disorders: preliminary data from a postmortem study
Journal of Neuropsychiatry and Clinical Neuroscience
Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F18
Archives of General Psychiatry
Reduction of prefrontal cortex glucose metabolism common to three types of depression
Archives of General Psychiatry
The anatomy of melancholia—focal abnormalities of cerebral blood flow in major depression
Psychological Medicine
Monoamine dysfunction and the pathophysiology and treatment of depression
Journal of Clinical Psychiatry
Change in basal ganglia volume over 2 years in patients with schizophrenia: typical vs. atypical neuroleptics
American Journal of Psychiatry
Depression and Parkinson's disease: a review
American Journal of Psychiatry
The neuroanatomy of depression
Journal of Clinical Psychiatry
Monoamines and the mechanism of antidepressant action: effects of catecholamine depletion on mood of patients treated with antidepressants
Psychopharmacology Bulletin
Wilson's disease. Psychiatric symptoms in 195 cases
Archives of General Psychiatry
Cited by (103)
Neuromelanin-sensitive magnetic resonance imaging in the study of mental disorder: A systematic review
2024, Psychiatry Research - NeuroimagingEvaluation of major depressive disorder using 7 Tesla phase sensitive neuroimaging before and after mindfulness-based cognitive therapy
2023, Journal of Affective DisordersCortical and subcortical morphological alterations in postpartum depression
2023, Behavioural Brain ResearchMaresin-1 improves LPS-induced depressive-like behavior by inhibiting hippocampal microglial activation
2023, Journal of Affective DisordersAlterations in CRY2 and PER3 gene expression associated with thalamic-limbic community structural abnormalities in patients with bipolar depression or unipolar depression
2022, Journal of Affective DisordersCitation Excerpt :In addition, Keith A et al. found an elevation in total neuron number in the limbic thalamus in a postmortem tissue analysis from individuals who had major depressive disorder in the Stanley Foundation Brain Bank (Young et al., 2004). On the other hand, GMV in the caudate nucleus, putamen, and other basal ganglia structures were not increased in individuals with major depressive disorder, suggesting that anatomical changes are selective for subcortical structures with limbic connections (Lacerda et al., 2003; Young et al., 2008). Patients with major depression have cortical abnormalities, including reduced volumes in the medial orbitofrontal cortex and prefrontal cortex, which may be associated with increased excitatory input to the thalamic cortex caused by excessive glutamate neuron projections (Klauser et al., 2015).